Abstract
Pleural effusions are resistant to standard therapy, which causes discomfort and can require prolonged hospitalization. As an alternative, pleuroperitoneal shunting for pleural effusions of various etiologies was evaluated. We implanted 36 shunts in 29 patients. Two patients had bilateral shunts and five had shunt revisions. The effusion was related to a malignancy in 22 patients, postoperative chylothorax in two patients, and other causes in five patients. Therapeutic thoracentesis had been attempted in 28 patients, and eight had had chest tube placement previously with attempted sclerosis. Seven patients had a trapped lung syndrome. There was no operative mortality. All patients were deemed ready for discharge from the hospital if they had recovered from the operation within 48 hours. Five patients had poor results, either because of a moribund status or their refusal or inability to pump the shunt. Of the remaining 24 patients, four had good results with temporary improvement, and excellent results were achieved in 20 patients (83.3%), who experienced symptomatic relief and stabilization or regression of pleural effusion until the time of their death. Patients with chylothorax experienced complete resolution. The 14 patients with malignant effusions had a median survival of 4 months, and there were no instances of peritoneal tumor seeding. In conclusion, pleuroperitoneal shunting is an alternative therapy for pleural effusions that requires a limited hospitalization only, is associated with minimal and short-term discomfort, achieves excellent results in properly selected patients, and is the only viable therapy when lung expansion cannot be achieved.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Albain K. S., Hoffman P. C., Little A. G., Bitran J. D., Golomb H. M., DeMeester T. R., Griem M. L., Blough R. R., Skosey C. Pleural involvement in stage IIIM0 non-small-cell bronchogenic carcinoma. A need to differentiate subtypes. Am J Clin Oncol. 1986 Jun;9(3):255–261. doi: 10.1097/00000421-198606000-00015. [DOI] [PubMed] [Google Scholar]
- Austin E. H., Flye M. W. The treatment of recurrent malignant pleural effusion. Ann Thorac Surg. 1979 Aug;28(2):190–203. doi: 10.1016/s0003-4975(10)63779-4. [DOI] [PubMed] [Google Scholar]
- Cimochowski G. E., Joyner L. R., Fardin R., Sarama R., Maran A. Pleuroperitoneal shunting for recalcitrant pleural effusions. J Thorac Cardiovasc Surg. 1986 Nov;92(5):866–870. [PubMed] [Google Scholar]
- Ferguson M. K., Little A. G., Skinner D. B. Current concepts in the management of postoperative chylothorax. Ann Thorac Surg. 1985 Dec;40(6):542–545. doi: 10.1016/s0003-4975(10)60345-1. [DOI] [PubMed] [Google Scholar]
- Hussain S. A. Pleuroperitoneal shunt in recurrent pleural effusions. Ann Thorac Surg. 1986 Jun;41(6):609–611. doi: 10.1016/s0003-4975(10)63071-8. [DOI] [PubMed] [Google Scholar]
- Little A. G., Ferguson M. K., Golomb H. M., Hoffman P. C., Vogelzang N. J., Skinner D. B. Pleuroperitoneal shunting for malignant pleural effusions. Cancer. 1986 Dec 15;58(12):2740–2743. doi: 10.1002/1097-0142(19861215)58:12<2740::aid-cncr2820581231>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
- Milsom J. W., Kron I. L., Rheuban K. S., Rodgers B. M. Chylothorax: an assessment of current surgical management. J Thorac Cardiovasc Surg. 1985 Feb;89(2):221–227. [PubMed] [Google Scholar]